Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02412956 · ClinicalTrials.gov registry record · NA
SmokefreeMOM: Reaching Pregnant Smokers With Health Information Via Text Messaging
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT02412956 is a NA study that has completed, run by George Washington University. The registered enrollment target is 99 participants.
The verdict
NCT02412956, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
Despite the great health benefits associated with smoking cessation in pregnancy to both mother and baby, few studies to date have examined the applications of text messaging or other communication technologies for smoking cessation in this population. This project is the first step in developing a new dissemination strategy for reaching pregnant smokers. This research will explore how a state-of -the-art, interactive and intensive, text messaging program, SmokefreeMoms Text, can promote smoking cessation in pregnant smokers. This program may have the potential to reach pregnant smokers who are not currently being reached with traditional smoking cessation services. The study Aims are: 1) to elicit qualitative feedback from pregnant smokers and recent quitters (in the past month) about the concept of SmokefreeMoms, the proposed message protocols in SmokefreeMoms, and the proposed messages in SmokefreeMoms (Phase 1); 2) To develop and pilot test a prototype of SmokefreeMoms which is consistent with Clinical Practice Guidelines (Phase 2), and 3) To conduct a formative evaluation of SmokefreeMoms 1.0 with pregnant smokers and recent quitters (Phase 3). 4) To measure the likelihood that pregnant women who smoke cigarettes will join an SMS program by responding to different types of recruitment messages.
Interventions
- BEHAVIORAL SmokefreeMOM Text
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02412956
The ClinicalTrials.gov registry entry for NCT02412956 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SmokefreeMOM Text is the first listed.
NCT02412956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02412956 about?
NCT02412956 is a clinical study titled "SmokefreeMOM: Reaching Pregnant Smokers With Health Information Via Text Messaging". Despite the great health benefits associated with smoking cessation in pregnancy to both mother and baby, few studies to date have examined the applications of text messaging or other communication technologies for smoking cessation in this population. This project is the first step in developing a ...
What is the current status of trial NCT02412956?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2013-01. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02412956?
The interventions under investigation include: SmokefreeMOM Text (BEHAVIORAL).
Who is sponsoring clinical trial NCT02412956?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.